BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34879281)

  • 1. Pan-cancer analysis reveals molecular patterns associated with age.
    Shah Y; Verma A; Marderstein AR; White J; Bhinder B; Garcia Medina JS; Elemento O
    Cell Rep; 2021 Dec; 37(10):110100. PubMed ID: 34879281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related somatic mutations in the cancer genome.
    Milholland B; Auton A; Suh Y; Vijg J
    Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive transcriptome profiling in elderly cancer patients reveals aging-altered immune cells and immune checkpoints.
    Wu Y; Wei J; Chen X; Qin Y; Mao R; Song J; Fan Y
    Int J Cancer; 2019 Apr; 144(7):1657-1663. PubMed ID: 30230534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
    Liu H; Zhang B; Sun Z
    Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive biomarkers for tumor-relevant signaling pathways in molecular pathology].
    Bonzheim I; Fend F
    Pathologe; 2014 Feb; 35(1):93-105. PubMed ID: 24496994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
    Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
    Front Immunol; 2021; 12():644350. PubMed ID: 34489925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Aging and Cancer: Role of miRNA in Tumor Microenvironment.
    Sandiford OA; Moore CA; Du J; Boulad M; Gergues M; Eltouky H; Rameshwar P
    Adv Exp Med Biol; 2018; 1056():137-152. PubMed ID: 29754179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic and molecular features distinguish young adult cancer from later-onset cancer.
    Lee W; Wang Z; Saffern M; Jun T; Huang KL
    Cell Rep; 2021 Nov; 37(7):110005. PubMed ID: 34788626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New ESMO scale ranks mutations as cancer medicine targets.
    Fricker J
    Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
    Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
    Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.
    Li Z; Chen S; Feng W; Luo Y; Lai H; Li Q; Xiu B; Li Y; Li Y; Huang S; Zhu X
    EBioMedicine; 2020 Dec; 62():103074. PubMed ID: 33161227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
    Varn FS; Schaafsma E; Wang Y; Cheng C
    Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.
    Chen F; Zhang Y; Gibbons DL; Deneen B; Kwiatkowski DJ; Ittmann M; Creighton CJ
    Clin Cancer Res; 2018 May; 24(9):2182-2193. PubMed ID: 29440175
    [No Abstract]   [Full Text] [Related]  

  • 17. A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence.
    Chatsirisupachai K; Palmer D; Ferreira S; de Magalhães JP
    Aging Cell; 2019 Dec; 18(6):e13041. PubMed ID: 31560156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative analysis of the age-associated multi-omic landscape across cancers.
    Chatsirisupachai K; Lesluyes T; Paraoan L; Van Loo P; de Magalhães JP
    Nat Commun; 2021 Apr; 12(1):2345. PubMed ID: 33879792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
    Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
    Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
    Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.